HomeALTME • EPA
add
TME Pharma NV
Nakaraang pagsara
€0.074
Sakop ng araw
€0.072 - €0.074
Sakop ng taon
€0.061 - €0.44
Market cap
6.53M EUR
Average na Volume
689.11K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.37M | -0.51% |
Net na kita | -1.62M | 11.23% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -1.34M | 0.07% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.70M | -10.14% |
Kabuuang asset | 2.94M | -15.02% |
Kabuuang sagutin | 1.38M | -62.07% |
Kabuuang equity | 1.57M | — |
Natitirang share | 42.12M | — |
Presyo para makapag-book | 1.85 | — |
Return on assets | -116.29% | — |
Return on capital | -217.64% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.62M | 11.23% |
Cash mula sa mga operasyon | -1.37M | 19.42% |
Cash mula sa pag-invest | -4.00K | 57.89% |
Cash mula sa financing | 1.60M | 78.88% |
Net change in cash | 229.00K | 128.17% |
Malayang cash flow | -723.12K | 3.18% |
Tungkol
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Itinatag
1997
Website
Mga Empleyado
13
